The newly approved Prodisc C Vivo, Prodisc C Nova and Prodisc C SK are all designed for cervical disc replacements, according to a July 13 company news release. They received the FDA’s pre-market application approval for single-level applications.
Prodisc C Vivo and Prodisc C Nova have been used outside the U.S. since 2009. Prodisc C Vivo is the most-used total disc replacement device outside the U.S.
The new approvals bring the devicemaker to four total cervical disc replacement devices with PMA approval.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
